Preoperative immunosuppression is not associated with increased postoperative complications following colectomy in children with colitis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 55, Issue 4, 2012, Pages 421-424

  Schaufler, Candi ^a   Lerer, Trudy ^a   Campbell, Brendan ^b   Weiss, Richard ^b   Cohen, Jeffrey ^b   Sayej, Wael ^a   Hyams, Jeffrey ^a  

^a Division of Pediatric Infectious Diseases   (United States)

^b HARTFORD HOSPITAL   (United States)

Author keywords

Children; Immunosuppression; Infliximab; Surgery; Ulcerative colitis

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; INFLIXIMAB; MERCAPTOPURINE; PREDNISONE;

ABDOMINAL ABSCESS; CHILD; COLON RESECTION; DEEP VEIN THROMBOSIS; FEMALE; HOSPITAL READMISSION; HUMAN; ILEOSTOMY; IMMUNOSUPPRESSIVE TREATMENT; LAPAROSCOPIC SURGERY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PANCOLITIS; PELVIS ABSCESS; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PRIORITY JOURNAL; PROCTOCOLECTOMY; RECTUM RESECTION; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SEPSIS; SMALL INTESTINE OBSTRUCTION; STAGING; SURGICAL INFECTION; ULCERATIVE COLITIS; URINARY TRACT INFECTION; WOUND DEHISCENCE;

ABDOMINAL ABSCESS; ADOLESCENT; ADRENAL CORTEX HORMONES; AGE FACTORS; ANTIBODIES, MONOCLONAL; CALCINEURIN; CHILD; CHRONIC DISEASE; COLECTOMY; COLITIS; COLITIS, ULCERATIVE; FEMALE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; INTESTINAL OBSTRUCTION; MALE; POSTOPERATIVE COMPLICATIONS; PREVALENCE; PURINES; RETROSPECTIVE STUDIES; SEPSIS; SEX FACTORS; WOUND INFECTION;

EID: 84867030074     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318252c831     Document Type: Review

References (13)

1. Hyams JS, Lerer T, Griffiths A, et al. Outcome following infliximab therapy in children with ulcerative colitis. Am J Gastroenterol 2010; 105:1430-6.
2. Hyams J, Markowitz J, Lerer T, et al. The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol 2006;4:1118-23. (Pubitemid 44311638)
3. Hyams JS, Lerer T, Mack D, et al. Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study. Am J Gastroenterol 2011;106:981-7.
4. Turner D, Travis SP, Griffiths AM, et al. Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol 2011;106:574-88.
5. Hyams JS, Davis P, Grancher K, et al. Clinical outcome of ulcerative colitis in children. J Pediatr 1996;129:81-8. (Pubitemid 26277250)
6. Gower-Rousseau C, Dauchet L, Vernier-Massouille G, et al. The natural history of pediatric ulcerative colitis: a population-based cohort study. Am J Gastroenterol 2009;104:2080-8.
7. Selvasekar CR, Cima RR, Larson DW, et al. Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 2007;204:956-63.
8. Schluender SJ, Ippoliti A, Dubinsky M, et al. Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis? Dis Colon Rectum 2007;50:1747-53. (Pubitemid 350077092)
9. Bousvaros A, Antonioli DA, Colletti RB, et al. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr 2007; 44:653-74.
10. Shen B. Impact of preoperative infliximab use on postoperative infectious complications in ulcerative colitis: the price we have to pay? Inflamm Bowel Dis 2008;14:1019-21.
11. Patton D, Gupta N, Wojcicki JM, et al. Postoperative outcome of colectomy for pediatric patients with ulcerative colitis. J Pediatr Gastroenterol Nutr 2010;51:151-4.
12. Kennedy R, Potter DD, Moir C, et al. Pediatric Chronic ulcerative colitis: does infliximab increase post-IPAA complications? J Pediatr Surg 2012;47:199-203.
13. Mor IJ, Vogel JD, da Luz Moreira A, et al. Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum 2008; 51:1202-10.